Showing results (91-100 of 165) with videos related to
Sort By:
Pageof 17
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factorsCristina L Ronchi, Virginia Varca, Paolo Beck-Peccoz, et al.European Journal of Endocrinology|December 1, 2017
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomasValeria Laufs, Barbara Altieri, Silviu Sbiera, et al.European Journal of Endocrinology|February 26, 2014
Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinomaBritta Heinze, Leonie J M Herrmann, Martin Fassnacht, et al.Frontiers in Endocrinology|December 7, 2020
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical CarcinomaIrina Chifu, Britta Heinze, Carmina T Fuss, et al.Case Reports in Endocrinology|December 4, 2025
Prolonged Mitotane Administration in Metastatic Adrenocortical Carcinoma With Over a Decade of Survival: A Case SeriesLorenzo Tucci, Mengjie Xu, Miriam Asia, et al.Cells|July 27, 2022
MicroRNAs and Long Non-Coding RNAs in Adrenocortical CarcinomaMario Detomas, Claudia Pivonello, Bianca Pellegrini, et al.Science Advances|February 20, 2021
PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser114 phosphorylationIsabel Weigand, Cristina L Ronchi, Jens T Vanselow, et al.Molecular and Cellular Endocrinology|May 17, 2024
Cellular landscape of adrenocortical carcinoma at single-nuclei resolutionDavid S Tourigny, Barbara Altieri, Kerim A Secener, et al.European Journal of Endocrinology|December 17, 2015
Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinomaMatthias Kroiss, Dietmar Plonné, Sabine Kendl, et al.European Journal of Endocrinology|February 9, 2011
Long-term effects of radiotherapy on cardiovascular risk factors in acromegalyCristina L Ronchi, Elisa Verrua, Emanuele Ferrante, et al.Pageof 17